Back to Browse Journals » Nanotechnology, Science and Applications » Volume 4

Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness

Authors Smijs TG, Pavel S

Published Date October 2011 Volume 2011:4 Pages 95—112

DOI http://dx.doi.org/10.2147/NSA.S19419

Published 13 October 2011

Video abstract presented by Threes Smijs

Views: 1186

Threes G Smijs1–3, Stanislav Pavel4
1Faculty of Science, Open University in The Netherlands, Rotterdam, The Netherlands; 2University of Leiden, Leiden Amsterdam Center for Drug Research, Leiden, The Netherlands; 3Erasmus MC, Center for Optical Diagnostics and Therapy, Rotterdam, The Netherlands; 4Charles University, Faculty of Medicine, Department of Dermatology, Pilsen, Czech Republic

Abstract: Sunscreens are used to provide protection against adverse effects of ultraviolet (UV)B (290–320 nm) and UVA (320–400 nm) radiation. According to the United States Food and Drug Administration, the protection factor against UVA should be at least one-third of the overall sun protection factor. Titanium dioxide (TiO2) and zinc oxide (ZnO) minerals are frequently employed in sunscreens as inorganic physical sun blockers. As TiO2 is more effective in UVB and ZnO in the UVA range, the combination of these particles assures a broad-band UV protection. However, to solve the cosmetic drawback of these opaque sunscreens, microsized TiO2 and ZnO have been increasingly replaced by TiO2 and ZnO nanoparticles (NPs) (<100 nm). This review focuses on significant effects on the UV attenuation of sunscreens when microsized TiO2 and ZnO particles are replaced by NPs and evaluates physicochemical aspects that affect effectiveness and safety of NP sunscreens. With the use of TiO2 and ZnO NPs, the undesired opaqueness disappears but the required balance between UVA and UVB protection can be altered. Utilization of mixtures of micro- and nanosized ZnO dispersions and nanosized TiO2 particles may improve this situation. Skin exposure to NP-containing sunscreens leads to incorporation of TiO2 and ZnO NPs in the stratum corneum, which can alter specific NP attenuation properties due to particle–particle, particle–skin, and skin–particle–light physicochemical interactions. Both sunscreen NPs induce (photo)cyto- and genotoxicity and have been sporadically observed in viable skin layers especially in case of long-term exposures and ZnO. Photocatalytic effects, the highest for anatase TiO2, cannot be completely prevented by coating of the particles, but silica-based coatings are most effective. Caution should still be exercised when new sunscreens are developed and research that includes sunscreen NP stabilization, chronic exposures, and reduction of NPs’ free-radical production should receive full attention.

Keywords: skin barrier, TiO2, ZnO, nanoparticles, physicochemical, scattering, blue shift, UV-radiation, (photo) toxicity, cancer

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Planning for interprofessional change in primary health care: exploring the use of the Interprofessional Resource Centre

Patterson C, Arthur H, Peachey G, Vohra J, Price D, Pearson D, Mariani R

Advances in Medical Education and Practice 2013, 4:117-125

Published Date: 14 May 2013

The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?

Panariti A, Miserocchi G, Rivolta I

Nanotechnology, Science and Applications 2012, 5:87-100

Published Date: 7 September 2012

Potential of magnetic nanoparticles for targeted drug delivery

Yang HW, Hua MY, Liu HL, Huang CY, Wei KC

Nanotechnology, Science and Applications 2012, 5:73-86

Published Date: 27 August 2012

A review of mammalian toxicity of ZnO nanoparticles

Vandebriel RJ, De Jong WH

Nanotechnology, Science and Applications 2012, 5:61-71

Published Date: 15 August 2012

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE

International Journal of Nanomedicine 2012, 7:2373-2388

Published Date: 8 May 2012

Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice

Xu N, Gu JL, Zhu YJ, Wen H, Ren QS, Chen JH

International Journal of Nanomedicine 2011, 6:905-913

Published Date: 28 April 2011

Evaluation of iron oxide nanoparticle biocompatibility

Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J

International Journal of Nanomedicine 2011, 6:787-794

Published Date: 14 April 2011

Gold nanoparticles: From nanomedicine to nanosensing

Po C Chen, Sandra C Mwakwari, Adegboyega K Oyelere

Nanotechnology, Science and Applications 2008, 1:45-66

Published Date: 2 November 2008

Applications of gold nanoparticles in cancer nanotechnology

Weibo Cai, Ting Gao, Hao Hong, Jiangtao Sun

Nanotechnology, Science and Applications 2008, 1:17-32

Published Date: 19 September 2008